These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34739404)

  • 1. Comparative Effectiveness and Safety of Polyethylene Glycol Electrolyte Solution Versus Lactulose for Treatment of Hepatic Encephalopathy: A Systematic Review and Meta-analysis.
    Li M; Zhang Z; Chen Q; Zhou X; Shui D; Huang J
    J Clin Gastroenterol; 2022 Jan; 56(1):41-48. PubMed ID: 34739404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial.
    Rahimi RS; Singal AG; Cuthbert JA; Rockey DC
    JAMA Intern Med; 2014 Nov; 174(11):1727-33. PubMed ID: 25243839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure.
    Ahmed S; Premkumar M; Dhiman RK; Kulkarni AV; Imran R; Duseja A; Kaur P; Taneja S; Singh V; Mishra S; Roy A; Mehtani R
    J Clin Gastroenterol; 2022 Jan; 56(1):e11-e19. PubMed ID: 33060437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy.
    Shehata HH; Elfert AA; Abdin AA; Soliman SM; Elkhouly RA; Hawash NI; Soliman HH
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1476-1481. PubMed ID: 30234645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis.
    Hoilat GJ; Ayas MF; Hoilat JN; Abu-Zaid A; Durer C; Durer S; Adhami T; John S
    BMJ Open Gastroenterol; 2021 May; 8(1):. PubMed ID: 34006606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic and stimulant laxatives for the management of childhood constipation.
    Gordon M; MacDonald JK; Parker CE; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009118. PubMed ID: 27531591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis.
    Luo M; Li L; Lu CZ; Cao WK
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1250-7. PubMed ID: 21971378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmotic and stimulant laxatives for the management of childhood constipation.
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy.
    Wang Z; Chu P; Wang W
    Drug Des Devel Ther; 2019; 13():1-11. PubMed ID: 30587923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2017 May; 5(5):CD001939. PubMed ID: 28518283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics for patients with hepatic encephalopathy.
    McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics for people with hepatic encephalopathy.
    Dalal R; McGee RG; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008716. PubMed ID: 28230908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial.
    Naderian M; Akbari H; Saeedi M; Sohrabpour AA
    Middle East J Dig Dis; 2017 Jan; 9(1):12-19. PubMed ID: 28316761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.